{"id":441776,"date":"2021-02-23T08:03:33","date_gmt":"2021-02-23T13:03:33","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=441776"},"modified":"2021-02-23T08:03:33","modified_gmt":"2021-02-23T13:03:33","slug":"pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/","title":{"rendered":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">CRANBURY, N.J., Feb.  23, 2021  (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President &amp; Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41<sup>st<\/sup> Annual Health Care Conference taking place virtually on March 1-4, 2021. The company will also participate in one-on-one investor meetings at the conference.<\/p>\n<p align=\"justify\">Panel details:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td colspan=\"2\" style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Cowen 41<sup>st<\/sup> Annual Health Care Conference Lung Cancer Panel<\/td>\n<\/tr>\n<tr>\n<td style=\"max-width:7%;width:7%;min-width:7%;text-align: justify;vertical-align: middle;vertical-align: top\">Date:<\/td>\n<td style=\"max-width:93%;width:93%;min-width:93%;text-align: justify;vertical-align: middle;vertical-align: top\">Tuesday, March 2, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">Time:<\/td>\n<td style=\"text-align: justify;vertical-align: middle;vertical-align: top\">11:10am<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        <strong>About PMV Pharma<\/strong>\n      <\/p>\n<p align=\"justify\">PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.\u00a0 PMV Pharma is headquartered in Cranbury, New Jersey. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7ouMJiM-13wRVtTwdvuizGMaOEoOwMy3ThlD_QiVFE13ZUZsgmZkDVPphiGIx1EBLtWqYNBW1lR5kSLuSAU-iw==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.pmvpharma.com<\/a>.<\/p>\n<p>Contact<\/p>\n<p>For Investors and Media:<\/p>\n<p>Winston Kung<br \/>Chief Financial Officer<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=--zYNEL709Tlnou9VYI2PI_HBDTFStFCqWBNW-KJ9a3au6jKZg3gOgB655IUZSJUyvq-9PMCwtUwUyq3GttX-DEPD4hQX35cq1Q_3IsoU0Q=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">investors@pmvpharma.com<\/a><\/u><\/p>\n<p>Source: PMV Pharmaceuticals, Inc.\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/cedd667a-983a-43ed-8667-d57c00a1e1b8\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>CRANBURY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President &amp; Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41st Annual Health Care Conference taking place virtually on March 1-4, 2021. The company will also participate in one-on-one investor meetings at the conference. Panel details: Cowen 41st Annual Health Care Conference Lung Cancer Panel Date: Tuesday, March 2, 2021 Time: 11:10am About PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-441776","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"CRANBURY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President &amp; Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41st Annual Health Care Conference taking place virtually on March 1-4, 2021. The company will also participate in one-on-one investor meetings at the conference. Panel details: Cowen 41st Annual Health Care Conference Lung Cancer Panel Date: Tuesday, March 2, 2021 Time: 11:10am About PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are &hellip; Continue reading &quot;PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-23T13:03:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference\",\"datePublished\":\"2021-02-23T13:03:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/\"},\"wordCount\":212,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/\",\"name\":\"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\",\"datePublished\":\"2021-02-23T13:03:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk","og_description":"CRANBURY, N.J., Feb. 23, 2021 (GLOBE NEWSWIRE) &#8212; PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants, today announced that David H. Mack, Ph.D., President &amp; Chief Executive Officer, will participate in the Lung Cancer Panel at the Cowen 41st Annual Health Care Conference taking place virtually on March 1-4, 2021. The company will also participate in one-on-one investor meetings at the conference. Panel details: Cowen 41st Annual Health Care Conference Lung Cancer Panel Date: Tuesday, March 2, 2021 Time: 11:10am About PMV Pharma PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are &hellip; Continue reading \"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-02-23T13:03:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference","datePublished":"2021-02-23T13:03:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/"},"wordCount":212,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/","name":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==","datePublished":"2021-02-23T13:03:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE1NzcyOSMzOTg5OTk4IzUwMDA3Nzc4OA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pmv-pharmaceuticals-announces-participation-at-the-cowen-41st-annual-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=441776"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/441776\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=441776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=441776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=441776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}